Literature DB >> 23670296

Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.

L Lo Nigro1, E Mirabile, M Tumino, C Caserta, G Cazzaniga, C Rizzari, D Silvestri, B Buldini, E Barisone, F Casale, M Luciani, F Locatelli, C Messina, C Micalizzi, A Pession, R Parasole, N Santoro, G Masera, G Basso, M Aricò, M Valsecchi, A Biondi, V Conter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23670296     DOI： 10.1038/leu.2013.149

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

Review 1.  Next-Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia.

Authors:  Emily B Heikamp; Ching-Hon Pui
Journal:  J Pediatr       Date:  2018-09-10       Impact factor: 4.406

2.  PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation.

Authors:  Wenbin Xiao; Maheetha Bharadwaj; Max Levine; Noushin Farnhoud; Friederike Pastore; Bartlomiej M Getta; Anne Hultquist; Christopher Famulare; Juan S Medina; Minal A Patel; Qi Gao; Natasha Lewis; Janine Pichardo; Jeeyeon Baik; Brian Shaffer; Sergio Giralt; Raajit Rampal; Sean Devlin; Robert Cimera; Yanming Zhang; Maria E Arcila; Elli Papaemmanuil; Ross L Levine; Mikhail Roshal
Journal:  Blood Adv       Date:  2018-12-11

3.  KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia.

Authors:  Fida Khater; Mathieu Lajoie; Sylvie Langlois; Jasmine Healy; Sonia Cellot; Chantal Richer; Patrick Beaulieu; Pascal St-Onge; Virginie Saillour; Mark Minden; Monia Marzouki; Maja Krajinovic; Henrique Bittencourt; Daniel Sinnett
Journal:  Blood       Date:  2017-01-09       Impact factor: 22.113

4.  HOXA-activated early T-cell progenitor acute lymphoblastic leukemia: predictor of poor outcome?

Authors:  Jules Pp Meijerink; Kirsten Canté-Barrett; Eric Vroegindeweij; Rob Pieters
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

Review 5.  Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.

Authors:  Sarah K Tasian; Stephen P Hunger
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

6.  Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.

Authors:  A Lonetti; I L Antunes; F Chiarini; E Orsini; F Buontempo; F Ricci; P L Tazzari; P Pagliaro; F Melchionda; A Pession; A Bertaina; F Locatelli; J A McCubrey; J T Barata; A M Martelli
Journal:  Leukemia       Date:  2013-11-06       Impact factor: 11.528

Review 7.  Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.

Authors:  Sarah K Tasian; Mignon L Loh; Stephen P Hunger
Journal:  Cancer       Date:  2015-07-20       Impact factor: 6.860

8.  Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL.

Authors:  Huining Kang; Nitesh D Sharma; Christian K Nickl; Meenakshi Devidas; Mignon L Loh; Stephen P Hunger; Kimberly P Dunsmore; Stuart S Winter; Ksenia Matlawska-Wasowska
Journal:  Biomark Res       Date:  2018-08-23

9.  A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML.

Authors:  Bo-Rui Chen; Anagha Deshpande; Karina Barbosa; Maria Kleppe; Xue Lei; Narayana Yeddula; Pablo Sánchez Vela; Alexandre Rosa Campos; Robert J Wechsler-Reya; Anindya Bagchi; Soheil Meshinchi; Connie Eaves; Irmela Jeremias; Torsten Haferlach; David A Frank; Ze'ev Ronai; Sumit Chanda; Scott A Armstrong; Peter D Adams; Ross L Levine; Aniruddha J Deshpande
Journal:  Blood       Date:  2021-06-17       Impact factor: 25.476

10.  MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.

Authors:  K Matlawska-Wasowska; H Kang; M Devidas; J Wen; R C Harvey; C K Nickl; S A Ness; M Rusch; Y Li; M Onozawa; C Martinez; B L Wood; B L Asselin; I-M Chen; K G Roberts; A Baruchel; J Soulier; H Dombret; J Zhang; R S Larson; E A Raetz; W L Carroll; N J Winick; P D Aplan; M L Loh; C G Mullighan; S P Hunger; N A Heerema; A J Carroll; K P Dunsmore; S S Winter
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.